Tag
pharmaceutical industry
-
•
GAO evaluates FDA’s overseas inspectors
A couple of new GAO reports are seeking to shed some light on the FDA’s overseas regulatory efforts. The first…
-
ProPublica investigates pharma payments to doctors
ProPublica’s massive investigation into the hefty fees pharmaceutical companies have paid doctors with dubious track records stamps an exclamation point…
-
•
More patients aren’t filling brand-name prescriptions
It hasn’t had quite as much impact as some earlier health-related recession trend stories, but the rise in prescription abandonment…
-
•
Rise, fall of two St. Louis pharma companies
Midwest Health Journalism Program fellow Jim Doyle, a reporter at the St. Louis Post-Dispatch, tells the story of Forest Pharmaceuticals…
-
•
Everyone reacts to Avandia roller coaster
First, the background: Avandia, also known as rosiglitazone, is an anti-diabetes drug that helps patients control their blood sugar. It…
-
•
New CME provider eschews industry money
Medical Marketing & Media‘s Marc Iskowitz profiles a new continuing medical education provider, Lighthouse Learning. Started by a Harvard neurologist…
-
•
Ethics professor takes on clinical trials, marketing
Writing for Mother Jones, University of Minnesota medical ethics professor Carl Elliott digs into the Dan Markingson story first covered…
-
•
FDA site tracks post-approval drug dangers
Thanks to new requirements, the FDA is now publishing updates on its safety evaluations of drugs that are already on…
-
•
Journalist recounts the pressure of GSK clinical trial
In the wake of questions about GlaxoSmithKline’s Avandia clinic trials, the Austin American-Statesman‘s Ana Cantú talks about her own experience…
-
•
Foreign trial data used in 4/5 of approved drugs
FairWarning’s Lea Yu and The New York Times‘ Gardiner Harris drew our attention to a report from the HHS Office…